At a glance
ClinicalIndex Comparison RecordN/ACompleted· 35 enrolled
Drug / intervention
e-Vapor Product A +3 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Characterization of Selected Aerosol Constituents Levels in the Exhaled Breath of Adult e-Vapor Users During Use of Four e-Vapor Products
In Brief
A clinical study evaluating e-Vapor Product A, e-Vapor Product B, and 2 other interventions for Tobacco Use. Completed, enrolled 35 participants across 1 site.
Detailed Summary
This is an open-label, 4-way crossover study designed to estimate the nicotine, glycerin, propylene glycol, menthol, formaldehyde, acetaldehyde, and acrolein levels in exhaled breath samples during use of four MarkTen® XL e-vapor products. The study will enroll approximately 32 adult e-vapor-using subjects at one site in the United States in High Point, NC.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsTobacco Use
CountriesUnited States
CollaboratorsCato Research
Timeline
N/ACompletedFinished
2017201820192020202120222023202420252026
Enrollment StartMar 2017
Primary CompletionApr 2017
Study CompletionJan 2018
First PostedMay 2021
TodayJul 2026
First PostedMay 11, 2021
Enrollment StartMar 27, 2017
Primary CompletionApr 21, 2017
Study CompletionJan 26, 2018
TodayJul 2, 2026
Enrollment to primary: 24 daysPosted 5.1 years ago
Interventions
e-Vapor Product Aother
e-Vapor product XL25F
e-Vapor Product Bother
e-Vapor product XL40CB
e-Vapor Product Cother
e-Vapor product XL35WM
e-Vapor Product Dother
e-Vapor product XL40MB